Personality, Addiction, Dopamine: Insights from Parkinson's Disease

被引:265
|
作者
Dagher, Alain [1 ]
Robbins, Trevor W. [2 ,3 ]
机构
[1] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[2] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England
[3] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
IMPULSE CONTROL DISORDERS; NUCLEUS-ACCUMBENS DOPAMINE; GOAL-DIRECTED BEHAVIOR; REWARD-RELATED STIMULI; BASAL GANGLIA; D-3; RECEPTOR; FRONTOTEMPORAL DEMENTIA; INCENTIVE SALIENCE; DRUG-ADDICTION; MESENCEPHALIC DOPAMINE;
D O I
10.1016/j.neuron.2009.01.031
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In rare instances, patients with Parkinson's disease (PD) may become addicted to their own medication or develop behavioral addictions such as pathological gambling. This is surprising because PD patients typically have a very low incidence of drug abuse and display a personality type that is the polar opposite of the addictive personality. These rare addictive syndromes, which appear to result from excessive dopaminergic medication use, illustrate the link between dopamine, personality, and addiction. We describe the clinical phenomena and attempt to relate them to current models of learning and addiction. We conclude that persistently elevated dopaminergic stimulation promotes the development and maintenance of addictive behaviors.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 50 条
  • [41] New insights into Parkinson’s disease
    Kenny K. K. Chung
    Valina L. Dawson
    Ted M. Dawson
    Journal of Neurology, 2003, 250 : iii15 - iii24
  • [42] Surgical insights into Parkinson's disease
    Pereira, Erlick A. C.
    Aziz, Tipu Z.
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (05) : 238 - 244
  • [43] Dopamine agonist switching in Parkinson's disease
    Stewart, D
    Morgan, E
    Burn, D
    Grosset, D
    Chaudhuri, KR
    MacMahon, D
    Needleman, F
    Macphee, G
    Heywood, P
    HOSPITAL MEDICINE, 2004, 65 (04): : 215 - 219
  • [44] Participation of dopamine in constipation of Parkinson's disease
    Sunagawa, Masataka
    Tanigawa, Hiroto
    Tokita, Erika
    Higuchi, Takeshi
    Guo, Shi-Yu
    Hisamitsu, Tadash
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2010, 60 : S202 - S202
  • [45] Impaired dopamine release in Parkinson's disease
    Cramb, Kaitlyn M. L.
    Beccano-Kelly, Dayne
    Cragg, Stephanie J.
    Wade-Martins, Richard
    BRAIN, 2023, 146 (08) : 3117 - 3132
  • [46] Dopamine agonists and neuroprotection in Parkinson's disease
    Olanow, CW
    Jenner, P
    Brooks, D
    ANNALS OF NEUROLOGY, 1998, 44 (03) : S167 - S174
  • [47] Dopamine and Parkinson's disease: is the killer in the house?
    Chesselet, MF
    MOLECULAR PSYCHIATRY, 2003, 8 (04) : 369 - 370
  • [48] Neurotransmission in Parkinson's disease: beyond dopamine
    Barone, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) : 364 - 376
  • [49] Intrathecal and intracerebroventricular dopamine for Parkinson's disease
    Abraham, Mickey E.
    Gold, Justin
    Dondapati, Akhil
    Gendreau, Julian
    Mammis, Antonios
    Herschman, Yehuda
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 200
  • [50] Dopamine agonist monotherapy in Parkinson's disease
    Clarke, CE
    Guttman, M
    LANCET, 2002, 360 (9347): : 1767 - 1769